Product
Engineer Blog Series: Security & Compliance with Tiffany HuangWelcome to Invert's Engineering Blog Series, a behind-the-scenes look into the product and how it's built. For our third post, senior software engineer Tiffany Huang speaks about how trust and security is a foundational principle at Invert, and how we ensure that data is kept secure, private, and compliant with industry regulations.
Product
Introducing Invert Assist — Explainable AI for Bioprocess Quality Control, Monitoring, and OptimizationBiopharma teams don’t fail at AI because models are weak. They stall because data is fragmented. In our new webinar, we introduced Invert Assist—the AI layer purpose-built for bioprocessing—and showed how pairing explainable AI with a trusted, harmonized data foundation accelerates scale-up, improves bioprocess quality control, and cuts wasted runs.
Product
Invert Launches Invert AssistToday, Invert launches Invert Assist, the first AI-powered analysis interface built for bioprocess. Using a simple chat interface, Invert Assist enables users to perform complex analysis that typically takes an expert team hours to code manually. With the freedom and flexibility of natural language, bioprocess scientists can turn days or even weeks of troubleshooting and optimization into a 5-minute conversation with their data.
Industry
AI That Bioprocess Teams Can Trust: Highlights from BioTalk BerlinRecorded live at BioTalk Berlin on September 18, 2025 — featuring Michael McCutchen, Senior Product Manager at Invert. Scroll to the end to watch the full talk.
Product
Engineer Blog Series: Invert Assist with Simon Sotak GregorInvert recently launched Invert Assist, our AI interface for bioprocess data analysis. We speak to senior software engineer Simon Sotak Gregor about Invert Assist to learn more about how it was built, what problems it solves, and how he hopes it’ll change the way bioprocess is done.
Product
Engineer Blog Series: Integrations with Julia MillerSenior software engineer Julia Miller speaks to us about Invert's integrations — how they're implemented, what makes them special, and what goes into making them work for bioprocess.
Product
Invert Launches Alerts: Turning Real Time Data Into Immediate ActionInvert Alerts transform real time bioprocess data into immediate, actionable notifications so scientists can act in the moment, protect their runs, and focus on advancing processes instead of manually monitoring them
Interviews
On-Demand Webinar: The Future of Data in BioprocessingDiscover how bioprocessing data is evolving from spreadsheets to AI-driven insights. Watch the on-demand webinar to future-proof your digital strategy.
Team
Meet Emily Nault, Invert’s New SVP of CommercialInvert is excited to announce that Emily Nault has joined the company as our Senior Vice President of Commercial.
Product
Why ELNs and LIMS are not enough for PD teamsOne of the questions we’re asked frequently is whether Invert is an ELN or LIMS—our answer is that Invert captures both systems’ strengths and fixes their weaknesses. We’ll discuss the trade-offs and shortcomings of ELN and LIMS when it comes to bioprocess data to explain how.
Invert’s lineage view connects products across every unit operation and material transfer throughout the entire process. It acts as a family tree for your product, tracing its origins back through purification, fermentation, and inoculation. Instead of manually tracking down the source of each data point, lineages automatically show material streams as they pass through each step.
In modern biomanufacturing, success hinges on the ability to make informed decisions fast. The ability to analyze data directly impacts productivity, product quality, and ultimately, time to market, whether you're optimizing a fed-batch fermentation, troubleshooting a chromatography run, or validating a filtration process. However, its massive volume, high dimensionality, and low latency of time series data in bioprocess means that most software are not built to effectively capture, let alone analyze it.
See why Invert is the best real-time bioprocess monitoring platform for pharmaceutical manufacturing and scale-up. Live data, AI insights, compliance-ready.
Pharmaceutical manufacturers face critical data integration challenges as bioprocess operations generate unprecedented volumes of fragmented information. Learn more about which leading platforms are also offering AI.
The bioprocess optimization market is growing from $24.3B in 2024 to $39.6B by 2029, fueled by the shift to AI-driven digital biomanufacturing. These AI bioprocess platforms are leading the charge.
